Literature DB >> 19262521

Long-term follow-up of ulcerative colitis in the Chinese population.

Dorothy K L Chow1, Rupert W L Leong, Kelvin K F Tsoi, Simon S M Ng, Wai-keung Leung, Justin C Y Wu, Vincent W S Wong, Francis K L Chan, Joseph J Y Sung.   

Abstract

OBJECTIVES: The incidence of ulcerative colitis (UC) in Asia is increasing but reports on its long-term course are few. We set out determine the incidence, prevalence, and survival rate of UC in the Chinese population and phenotypic stability by longitudinal follow-up.
METHODS: A cohort of Chinese UC patients were followed up in a tertiary referral center in Hong Kong between 1985 and 2006. Clinical data were prospectively collected since 2001. Population statistics were obtained from the Census and Statistics Department of Hong Kong for the calculation of age-specific incidence, prevalence, and survival. The disease phenotypes at diagnosis and upon follow-up were documented.
RESULTS: A total of 172 patients (51.7% men) with a median age at diagnosis of 37.0 years (range: 12.0-85.0) were included. The cohort was observed for a total of 1,393 person-years with a median follow-up duration of 7.0 years (range: 0.5-22.0). The age-standardized incidence and prevalence rates of UC per 100,000 were 2.1 (95% confidence interval, CI: 1.1-3.7) and 26.5 (95% CI: 22.6-30.9), respectively, in 2006. The 10-year cumulative rate of proximal extension was 23.8%. Only one patient developed colorectal cancer during the observation period. The cumulative colectomy rates were 2.4% and 7.6% at 1 and 10 years of follow-up. Overall survival was similar to that expected (P=0.07).
CONCLUSIONS: The incidence of UC has increased sixfold in the past two decades in Hong Kong. The complication, colorectal cancer, and colectomy rates are low in Chinese patients but increase with duration of illness.

Entities:  

Mesh:

Year:  2009        PMID: 19262521     DOI: 10.1038/ajg.2008.74

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

Review 2.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

3.  Expression and implication of toll-like receptors TLR2, TLR4 and TLR9 in colonic mucosa of patients with ulcerative colitis.

Authors:  Yan Tan; Kai-Fang Zou; Wei Qian; Sheng Chen; Xiao-Hua Hou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

Review 4.  Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis.

Authors:  Xinxin Yang; Jingshu Geng; Hongxue Meng
Journal:  Histol Histopathol       Date:  2020-07-24       Impact factor: 2.303

5.  Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Keisuke Hata; Satoshi Okada; Soichiro Ishihara; Koji Morimoto; Rikisaburo Sahara; Kazuhiro Watanabe; Kouhei Fukushima; Kenichi Takahashi; Hideaki Kimura; Keiji Hirata; Tsunekazu Mizushima; Toshimitsu Araki; Masato Kusunoki; Riichiro Nezu; Sayumi Nakao; Michio Itabashi; Akira Hirata; Heita Ozawa; Takashi Ishida; Koji Okabayashi; Takayuki Yamamoto; Toshihiro Noake; Junya Arakaki; Yusuke Watadani; Hiroki Ohge; Ryo Futatsuki; Kazutaka Koganei; Akira Sugita; Daijiro Higashi; Kitaro Futami
Journal:  Surg Today       Date:  2019-07-15       Impact factor: 2.549

6.  Race and inflammatory bowel disease in an urban healthcare system.

Authors:  Justin L Sewell; John M Inadomi; Hal F Yee
Journal:  Dig Dis Sci       Date:  2010-10-09       Impact factor: 3.199

7.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

8.  Indian Society of Gastroenterology consensus on ulcerative colitis.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Philip Abraham; Uday C Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra C Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Anna Pulimood; Amarender S Puri; Ganesh N Ramesh; Gautam Ray; Shivaram P Singh; Ajit Sood; Manu Tandan
Journal:  Indian J Gastroenterol       Date:  2012-10-25

9.  Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis.

Authors:  Masaki Ujihara; Takafumi Ando; Kazuhiro Ishiguro; Osamu Maeda; Osamu Watanabe; Yutaka Hirayama; Kazuhiro Morise; Keiko Maeda; Masanobu Matsushita; Ryoji Miyahara; Naoki Ohmiya; Yuji Nishio; Takeo Yamaguchi; Jun-Ichi Haruta; Kenji Ina; Hidemi Goto
Journal:  BMC Res Notes       Date:  2013-05-25

Review 10.  Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts.

Authors:  Lester Tsai; Christopher Ma; Parambir S Dulai; Larry J Prokop; Samuel Eisenstein; Sonia L Ramamoorthy; Brian G Feagan; Vipul Jairath; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-27       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.